Related references
Note: Only part of the references are listed.Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
David S. Knopman et al.
BRAIN (2019)
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers
Brian A. Gordon et al.
BRAIN (2019)
Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis
Antoine Leuzy et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project
Tessa Timmers et al.
NEUROBIOLOGY OF AGING (2019)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson et al.
BRAIN (2019)
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D. Rabinovici et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Bernard J. Hanseeuw et al.
JAMA NEUROLOGY (2019)
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
Renaud La Joie et al.
ALZHEIMERS & DEMENTIA (2019)
Alzheimer's disease is neither Alzheimer's clinical syndrome nor dementia
William Jagust et al.
ALZHEIMERS & DEMENTIA (2019)
A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
Christopher G. Schwarz et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging
Anne Maass et al.
JOURNAL OF NEUROSCIENCE (2018)
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia
K. Chiotis et al.
MOLECULAR PSYCHIATRY (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
Rachel F. Buckley et al.
ALZHEIMERS & DEMENTIA (2018)
Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults
Murat Bilgel et al.
BRAIN (2018)
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis
Hugo Botha et al.
BRAIN (2018)
Subthreshold Amyloid Predicts Tau Deposition in Aging
Stephanie L. Leal et al.
JOURNAL OF NEUROSCIENCE (2018)
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
Brian A. Gordon et al.
LANCET NEUROLOGY (2018)
Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality
Oscar L. Lopez et al.
NEUROLOGY (2018)
Tau-negative amnestic dementia masquerading as Alzheimer disease dementia
Hugo Botha et al.
NEUROLOGY (2018)
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease
Yen Ying Lim et al.
JAMA NEUROLOGY (2018)
Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort The ABIDE Project
Arno de Wilde et al.
JAMA NEUROLOGY (2018)
Association of Cerebral Amyloid-beta Aggregation With Cognitive Functioning in Persons Without Dementia
Willemijn J. Jansen et al.
JAMA PSYCHIATRY (2018)
How early can we diagnose Alzheimer disease (and is it sufficient)? The 2017 Wartenberg lecture
Ronald C. Petersen
NEUROLOGY (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia
Val J. Lowe et al.
BRAIN (2018)
AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies
Kejal Kantarci et al.
ANNALS OF NEUROLOGY (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
Shruti Mishra et al.
NEUROIMAGE (2017)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Anne Maass et al.
NEUROIMAGE (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
Laetitia Lemoine et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Effectiveness of Florbetapir PET Imaging in Changing Patient Management
Michael J. Pontecorvo et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2017)
Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum
David T. Jones et al.
CORTEX (2017)
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
Marta Marquie et al.
ACTA NEUROPATHOLOGICA (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
THE TAU METER SCALE FOR THE GENERATION OF CONTINUOUS AND CATEGORICAL MEASURES OF TAU DEPOSITS IN THE BRAIN: RESULTS FROM 18F-AV1451 AND 18F-THK5351 TAU IMAGING STUDIES
Victor L. Villemagne et al.
Alzheimers & Dementia (2016)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
Chengjie Xiong et al.
NEUROLOGY (2016)
Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI
Susan M. Landau et al.
NEUROLOGY (2016)
Tau PET in Alzheimer disease and mild cognitive impairment
Hanna Cho et al.
NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
Stephen N. Gomperts et al.
JAMA NEUROLOGY (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
Lauren Walker et al.
ACTA NEUROPATHOLOGICA (2015)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum
Melissa E. Murray et al.
BRAIN (2015)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Suspected non-AD pathology in mild cognitive impairment
Laura E. M. Wisse et al.
NEUROBIOLOGY OF AGING (2015)
Multiple pathologies are common and related to dementia in the oldest-old The 90+Study
Claudia H. Kawas et al.
NEUROLOGY (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
Tammie L. S. Benzinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Amyloid imaging in dementias with atypical presentation
David A. Wolk et al.
ALZHEIMERS & DEMENTIA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Generalizability of Epidemiological Findings and Public Health Decisions: An Illustration From the Rochester Epidemiology Project
Jennifer L. St Sauver et al.
MAYO CLINIC PROCEEDINGS (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Alzheimer's disease is not brain aging: neuropathological, genetic, and epidemiological human studies
Peter T. Nelson et al.
ACTA NEUROPATHOLOGICA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
A. Forsberg et al.
CURRENT ALZHEIMER RESEARCH (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
A beta Amyloid and Glucose Metabolism in Three Variants of Primary Progressive Aphasia
Gil D. Rabinovici et al.
ANNALS OF NEUROLOGY (2008)
The Mayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics
Rosebud O. Roberts et al.
NEUROEPIDEMIOLOGY (2008)
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Julie A. Schneider et al.
NEUROLOGY (2007)
Pathological correlates of dementia in a longitudinal, population-based sample of aging
Joshua A. Sonnen et al.
ANNALS OF NEUROLOGY (2007)
Neuropathologic substrate of mild cognitive impairment
WR Markesbery et al.
ARCHIVES OF NEUROLOGY (2006)
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
M Ingelsson et al.
NEUROLOGY (2004)
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function
DA Bennett et al.
ARCHIVES OF NEUROLOGY (2004)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)